跳至主要内容
临床试验/NCT06629090
NCT06629090招募中2 期

Cerebrovascular Responses to Acute Hypoperfusion

University of Wisconsin, Madison1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2025年12月17日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
36
试验地点
1
主要终点
Change in blood velocity

研究概览

简要总结

Brain blood flow will be measured during a simulated postural change test and while breathing increased levels of carbon dioxide using magnetic resonance imaging.

详细描述

Global cerebral blood flow (CBF) decreases with advancing age; however, some adults have accelerated declines in CBF, placing them at a greater risk of cognitive impairment. However, there is a lack of human studies that investigate the cause or consequence of altered blood flow regulation in the brain. This study will systematically address this gap in knowledge by examining cerebrovascular control in adults during acute physiological challenges (simulated postural change test and breathing increased carbon dioxide) that stimulate a change in CBF.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Between the ages of 20-40 years
  • Have a BMI ≤34.5 kg/m2
  • are less than 72 in (182.88 cm) height
  • Nonsmoker

排除标准

  • Diagnosis of Mild Cognitive Impairment (MCI) or Alzheimer's disease (AD)
  • History or evidence of hepatic disease, hematological disease, or peripheral vascular disease; severe kidney injury requiring hemodialysis
  • History of cardiovascular disease including: severe congestive heart failure, coronary artery disease, ischemic heart disease (stents, coronary artery bypass grafts) and tachycardia
  • Uncontrolled hypertension
  • History of clinically significant ischemic or hemorrhagic stroke, or significant cerebrovascular disease
  • Severe untreated obstructive sleep apnea
  • History of diabetes with HbA1c greater than 9.5 percent
  • Major neurologic disorders other than dementia (e.g., MS, ALS, brain surgery, etc.)
  • Current or recent (less than1 year) major psychiatric condition (Axis I) or addictive disorders
  • Significant surgical history
  • Other significant medical conditions at investigators' discretion
  • Contraindications to MRI
  • Prescribed medications that interfere with prazosin
  • Lactose allergy
  • lower body will not fit in lower body negative pressure (LBNP) chamber (regardless of overall height and BMI)

研究组 & 干预措施

Young Adults

Experimental

Young Adults between 20-40 years of age.

干预措施: MRI (Device)

Young Adults

Experimental

Young Adults between 20-40 years of age.

干预措施: Placebo (Drug)

Young Adults

Experimental

Young Adults between 20-40 years of age.

干预措施: Prazosin (Drug)

结局指标

主要结局

Change in blood velocity

时间窗: Two study visits, up to 240 minutes

The change in blood velocity during breathing and simulated postural change tasks will be measured with MRI

Change in blood flow

时间窗: Two study visits, up to 240 minutes

The change in intracranial blood flow during breathing and simulated postural change tasks will be measured with MRI

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验